clinical trial · NCT05658484
A Study of Dimethyl Fumarate (DMF) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in China
Biogen·phase4·completed·n = 60
Multiple SclerosisDimethyl fumarate
brief summary
The primary objective of the study is to assess the efficacy of DMF in Chinese participants with RMS at Week 48. The secondary objectives of the study are to assess the efficacy and safety of DMF in Chinese participants with RMS.
started
Jun 9, 2023
primary completion
Mar 27, 2025
completion
Apr 12, 2025
last updated
May 16, 2025
official title
A Multicenter, Postmarketing Study of Dimethyl Fumarate (Tecfidera; BG00012) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in China
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol